Research and Markets (http://www.researchandmarkets.com/research/wh5dvw/brazilian_market) has announced the addition of the "Brazilian Market for Orthopedic Trauma Devices (Executive Summary)" report to their offering.
In 2011, the total Brazilian market for orthopedic trauma devices was valued at over $460 million. This market includes plates and screws, intramedullary nails, hip intramedullary nails, compression hip screws, cannulated screws and external fixation devices. All of these segments experienced positive growth in 2011, as the aging population and the high number of motor vehicle accidents in Brazil continued to drive demand. The overall market is largely divided in terms of pricing set by the public SUS system and prices influenced by private insurance companies. The ASPs of products purchased through public healthcare are stable; however, there has been a gradual decline in ASPs in the private healthcare sector. Overall, the strong positive growth in all segments will allow the entire market to grow rapidly over the 2011-2018 forecast period.
Scope: This report pertains to a forecast period of 10 years (2008 - 2018) for Brazil.
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
Companies Mentioned
- Orthofix
- Baumer
- DePuy
- Biomet
- Smith & Nephew
- Biomecanica
- NeoOrtho
- Osteomed
- Zimmer
- Hexagon
- GM Reis
- Acumed
- GE Hospitalar
- Ortocir
- Sartori
- Ortosintese
- Aesculap
- MDT
- Traumedica
- Synthes
- Stryker
- IOL
For more information visit http://www.researchandmarkets.com/research/wh5dvw/brazilian_market
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical
Devices
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.